Colorado Therapeutics Appoints Medtronic Executive John Lorbiecki as Chief Operating Officer in Advance of XI-S+™ Launch BROOMFIELD, Colo., May 15, 2017 (GLOBE NEWSWIRE) -- Colorado Therapeutics LLC, a commercial-stage medical device company with a proprietary technology platform for the production of innovative...

Colorado Therapeutics and Micro Interventional Devices Enter into a License Agreement for Use of the PolyCor™ Anchoring Technology BROOMFIELD, Colo, Oct. 28, 2016 (GLOBE NEWSWIRE) -- Colorado Therapeutics LLC, a privately held medical device company with a proprietary technology platform for the production of innovative...

Colorado Therapeutics Receives 510(k) Clearance for a Novel Xenograft Implant for Soft Tissue Repairs Broomfield, CO, Oct. 21, 2016 (GLOBE NEWSWIRE) -- Colorado Therapeutics LLC, a privately held medical device company with a proprietary technology platform for the production of innovative...

Colorado Therapeutics Submits 510(k) for a Novel Xenograft Implant for Soft Tissue Repairs BROOMFIELD, CO , Jan. 28, 2016 (GLOBE NEWSWIRE) -- Colorado Therapeutics LLC, a privately held medical device company that is leveraging over 15 years of innovative and proprietary cross-linked...